This new vaccine, approved by UK regulator, was developed by the University of Oxford with the British group AstraZeneca Plc.

The AstraZeneca vaccine benefits from a novel technology that uses genetic information of the coronavirus. The genetic code is injected into human cells to create an immune reaction